Delivery Order SPE2DB24D3013-SPE2DB25FFMUX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, represents pharmaceutical procurement under the company's larger contract vehicle with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a $3,298.53 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $7,961.64 to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens with an ultimate completion date of September 3, 2025. This competitively awarded, firm fixed-price contract represents a small-value transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be performed at the contractor's corporate headquarters in...
- The Defense Logistics Agency awarded a $3,118.79 firm fixed price delivery order to AmerisourceBergen Drug Corp for Trulicity 4.5 mg/0.5 mL pens on August 5, 2025, with an ultimate completion date of August 6, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery will be performed at the vendor's corporate...
- The Defense Logistics Agency awarded a $11,264.56 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pens on December 20, 2025, with completion scheduled for December 22, 2025. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $1,490.03 delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 ml pens on September 11, 2025, with completion expected by September 12, 2025. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a $5,657 delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pens in 0.5 ml quantities. This firm fixed price, non-set-aside contract is scheduled for completion by December 12, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $4,485.66 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens (0.5 mL). The contract, which is classified as a non-set-aside competitive award, is scheduled for completion by August 21, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens valued at $8,408.40 with a completion date of September 30, 2025. This non-competitive delivery order represents a firm fixed price transaction executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply agreement running through...
- The Defense Logistics Agency awarded a $13,692.03 delivery order to AmerisourceBergen Drug Corp on June 13, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 16, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete transaction under AmerisourceBergen's broader...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFMUXDelivery Order
The Defense Logistics Agency awarded a $2,044.08 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens (0.5 mL quantity). The contract, which is not set-aside, is scheduled for completion by June 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company's comprehensive IDC vehicle enables the supply of a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The current delivery order for Trulicity, a diabetes medication, exemplifies the company's role in fulfilling federal medical supply requirements through competitively awarded contracts and demonstrates its capability to serve the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 6/25/25 |